RTSM Software Isn't One-Size-Fits-All, Especially For Small Biotechs

Smaller biotech companies often have very different clinical trial needs than large pharmaceutical organizations, and that includes RTSM. In this clip, Ryan Keane explains why many legacy RTSM vendors, built to support large pharma, can struggle to keep up with the speed and flexibility emerging Sponsors require.

He highlights the value of working with a provider that aligns with your team’s pace, responsiveness, and operational needs. For growing biotechs, selecting the right RTSM platform can help simplify trial execution instead of adding unnecessary complexity.